Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice
Open Access
- 27 January 2011
- journal article
- Published by Wiley in Aging Cell
- Vol. 10 (3), 418-428
- https://doi.org/10.1111/j.1474-9726.2011.00680.x
Abstract
Trafficking through the secretory pathway is known to regulate the maturation of the APP-cleaving secretases and APP proteolysis. The coupling of stress signaling and pathological deterioration of the brain in Alzheimer’s disease (AD) supports a mechanistic connection between endoplasmic reticulum (ER) stress and neurodegeneration. Consequently, small molecular chaperones, which promote protein folding and minimize ER stress, might be effective in delaying or attenuating the deleterious progression of AD. We tested this hypothesis by treating APPswePS1delta9 AD transgenic mice with the molecular chaperone phenylbutyric acid (PBA) for 14 months at a dose of 1 mg PBA g−1 of body weight in the drinking water. Phenylbutyric acid treatment increased secretase-mediated APP cleavage, but was not associated with any increase in amyloid biosynthesis. The PBA-treated AD transgenic mice had significantly decreased incidence and size of amyloid plaques throughout the cortex and hippocampus. There was no change in total amyloid levels suggesting that PBA modifies amyloid aggregation or pathogenesis independently of biogenesis. The decrease in amyloid plaques was paralleled by increased memory retention, as PBA treatment facilitated cognitive performance in a spatial memory task in both wild-type and AD transgenic mice. The molecular mechanism underlying the cognitive facilitation of PBA is not clear; however, increased levels of both metabotropic and ionotropic glutamate receptors, as well as ADAM10 and TACE, were observed in the cortex and hippocampus of PBA-treated mice. The data suggest that PBA ameliorates the cognitive and pathological features of AD and supports the investigation of PBA as a therapeutic for AD.This publication has 52 references indexed in Scilit:
- ER Stress-Mediated Apoptotic Pathway Induced by Aβ Peptide Requires the Presence of Functional MitochondriaJournal of Alzheimer's Disease, 2010
- Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's diseaseBrain Research, 2009
- Increased Aβ1-42 Production Sensitizes Neuroblastoma Cells for ER Stress ToxicityCurrent Alzheimer Research, 2008
- Genetic aspects of Alzheimer diseaseGenetics in Medicine, 2008
- Assembly, Maturation, and Trafficking of the γ-Secretase Complex in Alzheimers DiseaseCurrent Alzheimer Research, 2008
- Aβ 1-42 Induces Mild Endoplasmic Reticulum Stress in an Aggregation State–Dependent MannerAntioxidants and Redox Signaling, 2007
- Chemical Chaperones Reduce Endoplasmic Reticulum Stress and Prevent Mutant HFE Aggregate FormationOnline Journal of Public Health Informatics, 2007
- Presenilin clinical mutations can affect γ‐secretase activity by different mechanismsJournal of Neurochemistry, 2006
- Exchange of N-CoR Corepressor and Tip60 Coactivator Complexes Links Gene Expression by NF-κB and β-Amyloid Precursor ProteinCell, 2002
- A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60Science, 2001